Abstract:We recently reported that adoptively transferred (AT) exogenous CD4+ CD25+ regulatory T cells (Tregs) to wild-type (WT) mice can directly act to repress shock/sepsis-induced experimental indirect acute lung injury (iALI), and this is mediated in part by programmed cell death receptor 1 (PD-1). In this study, we further determine whether recipient mouse lacking PD-L1, one of the primary ligands for PD-1, contributes to the manipulation of the Tregs' capacity to repress lung injury. To do this, Tregs isolated from the spleen of WT mice were AT into PD-L1 mice subjected to hemorrhagic shock and subsequent to cecal ligation and puncture to induce iALI. Samples were collected for analyses 24 h after cecal ligation and puncture. We found that in PD-L1-recipient mice, AT WT-Tregs lost the ability to reverse the development of iALI seen in WT recipient mice (i.e., no reduction of lung injury indices assessed by histology and vascular leakage, failure to decrease the lung neutrophil influx [myeloperoxidase activity], or the rise in lung apoptosis [caspase 3 activity]). Also, a significant increase in interleukin 1β (IL-1β) and keratinocyte-derived chemokine, but no changes in IL-6, IL-10, and IL-17A levels in lung tissues were seen in these mice compared with iALI mice without AT of Tregs. Furthermore, we noted that the lung tissue tyrosine phosphatase Src homology region 2 domain-containing phosphatase 1 (SHP-1), but not SHP-2, was activated with the AT of Tregs in PD-L1(-/-) iALI mice. Finally, through local depletion of CD4+ T cells or CD25+ (Tregs) in the lung, prior to inducing iALI, we found that SHP-1 activation was associated with the loss of Tregs' protective effects in vivo. Collectively, our data reveal that PD-L1 is a critical modulator of Tregs' ability to suppress iALI, and this appears to involve SHP-1 activation.

Program Death-1 Regulates Peripheral T Cell Tolerance Via an Anergy-Independent Mechanism

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

PD-1 negatively regulates helper T cell differentiation into Th2

Program Death-1 Suppresses Autoimmune Arthritis by Inhibiting Th17 Response.

Strength of PD-1 Signaling Differentially Affects T-cell Effector Functions

Overexpression of Programmed Death Ligand 1 in Dendritic Cells Inhibits Allogeneic Lymphocyte Activation in Mice

PD-1 Controls Follicular T Helper Cell Positioning and Function

PD-1 protects expanding human T cells from premature restimulation-induced cell death.

Targeted depletion of PD-1–expressing cells induces immune tolerance through peripheral clonal deletion

T-bet Interferes with PD-1/PD-L1-mediated Suppression of CD4+ T Cell Inflammation and Survival in Crohn's Disease.

PD-1 regulation in immune homeostasis and immunotherapy

PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer

Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells

PD-1 signaling facilitates activation of lymphoid tissue inducer cells by restraining fatty acid oxidation

Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo

The diverse functions of the PD1 inhibitory pathway

The role of PD-1 signaling in health and immune-related diseases

PD-L1-deficient Mice Show That PD-L1 on T Cells, Antigen-Presenting Cells, and Host Tissues Negatively Regulates T Cells

Programmed cell death receptor ligand 1 modulates the regulatory T cells' capacity to repress shock/sepsis-induced indirect acute lung injury by recruiting phosphatase SRC homology region 2 domain-containing phosphatase 1.

PD1 inhibits PKCθ-dependent phosphorylation of cytoskeleton-related proteins and immune synapse formation

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation